Abstract
Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Current Computer-Aided Drug Design
Title: Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions
Volume: 4 Issue: 1
Author(s): Shikha Varma-O'Brien, Frank K. Brown, Andrew LeBeau and Robert D. Brown
Affiliation:
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Abstract: Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Export Options
About this article
Cite this article as:
Varma-O'Brien Shikha, Brown K. Frank, LeBeau Andrew and Brown D. Robert, Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions, Current Computer-Aided Drug Design 2008; 4 (1) . https://dx.doi.org/10.2174/157340908783769274
DOI https://dx.doi.org/10.2174/157340908783769274 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors
Current Drug Therapy Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Current Angiogenesis (Discontinued) Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Molecular Pharmacology of Non-L-type Calcium Channels
Current Pharmaceutical Design Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology Cardioprotection Against Ischemia/Reperfusion Injury and Chromogranin ADerived Peptides
Current Medicinal Chemistry Nanodiagnostic Attainments and Clinical Perspectives on C-Reactive Protein: Cardiovascular Disease Risks Assessment
Current Medicinal Chemistry Vitamin D: A Regulator of Metabolism and Inflammation
Current Nutrition & Food Science A Review on Recent Patents in Digital Processing for Cardiac Electric Signals (I): From Basic Systems to Arrhythmia Analysis
Recent Patents on Biomedical Engineering (Discontinued) The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research
Current Alzheimer Research Knowledge and Awareness of Oral Manifestations of Diabetes Mellitus and Oral Health Assessment among Diabetes Mellitus Patients- A Cross Sectional Study
Current Diabetes Reviews Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
Current Medicinal Chemistry Drug Acyl Glucuronides: Reactivity and Analytical Implication
Current Pharmaceutical Analysis Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease
Current Vascular Pharmacology Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Current Pharmaceutical Design